Combination of iLux Photothermal Pulsation Therapy with 0.05% Cyclosporine in the Treatment of Meibomian Gland Dysfunction: A Clinical Study

Hongliang Xu, Qian Kang Department of Ophthalmology, Aidi Eye Hospital, Chengdu, Sichuan, People’s Republic of ChinaCorrespondence: Qian Kang, Department of Ophthalmology, Aidi Eye Hospital, No. 41.43.45, West Second Section, Second Ring Road, Qingyang District, Chengdu, 610031, Sichuan, People’s Re...

Full description

Saved in:
Bibliographic Details
Main Authors: Xu H, Kang Q
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:International Journal of General Medicine
Subjects:
Online Access:https://www.dovepress.com/combination-of-ilux-photothermal-pulsation-therapy-with-005-cyclospori-peer-reviewed-fulltext-article-IJGM
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849706231708516352
author Xu H
Kang Q
author_facet Xu H
Kang Q
author_sort Xu H
collection DOAJ
description Hongliang Xu, Qian Kang Department of Ophthalmology, Aidi Eye Hospital, Chengdu, Sichuan, People’s Republic of ChinaCorrespondence: Qian Kang, Department of Ophthalmology, Aidi Eye Hospital, No. 41.43.45, West Second Section, Second Ring Road, Qingyang District, Chengdu, 610031, Sichuan, People’s Republic of China, Email Xu_hongliang12@163.comObjective: The aim of this study is to investigate the effect of iLux with 0.05% cyclosporine in the treatment of meibomian gland dysfunction.Methods and Materials: In retrospective analysis, 72 patients of meibomian gland dysfunction were selected and divided into combination groups according to different treatment methods (n=32, iLux + 0.05% cyclosporine ophthalmic fluid) and the conventional group (n=44, 0.05% cyclosporine ophthalmic fluid). Compare the two groups of baseline data and clinical efficacy difference, compare the two groups after treatment eye symptoms, eye surface disease index score change.Results: Overall response rate of the combined group was higher than the conventional group (P < 0.05). Post-treatment, both groups were improved differently (P < 0.05), however, in the combined group, ocular symptom score, ocular surface disease index, conjunctival congestion score, corneal fluorescent staining score, meibomian gland (ostium condition score, lipid secretion shape score, deletion score) and interleukin-6, interleukin-1 β were all lower than those in the conventional group, The non-invasive mean tear film break-up time (NIBUTav), non-invasive first tear film break-up time (NIBUTf) and tear meniscus height in the combined group were higher than the conventional group (P < 0.05).Conclusion: ILux meibomian gland photothermal pulsation complex therapy instrument combined with 0.05% cyclosporine ophthalmic solution for the treatment of meibomian gland dysfunction.Keywords: meibomian gland dysfunction, iLux eyelid gland photothermal pulsatile compound therapy instrument, cyclosporine ophthalmic solution, treatment effect, patients
format Article
id doaj-art-698b0ee306f24275a95ecdf3aa95f3b5
institution DOAJ
issn 1178-7074
language English
publishDate 2025-07-01
publisher Dove Medical Press
record_format Article
series International Journal of General Medicine
spelling doaj-art-698b0ee306f24275a95ecdf3aa95f3b52025-08-20T03:16:15ZengDove Medical PressInternational Journal of General Medicine1178-70742025-07-01Volume 18Issue 141694179105347Combination of iLux Photothermal Pulsation Therapy with 0.05% Cyclosporine in the Treatment of Meibomian Gland Dysfunction: A Clinical StudyXu H0Kang Q1Cornea and External Diseases SpecialtyDepartment of OphthalmologyHongliang Xu, Qian Kang Department of Ophthalmology, Aidi Eye Hospital, Chengdu, Sichuan, People’s Republic of ChinaCorrespondence: Qian Kang, Department of Ophthalmology, Aidi Eye Hospital, No. 41.43.45, West Second Section, Second Ring Road, Qingyang District, Chengdu, 610031, Sichuan, People’s Republic of China, Email Xu_hongliang12@163.comObjective: The aim of this study is to investigate the effect of iLux with 0.05% cyclosporine in the treatment of meibomian gland dysfunction.Methods and Materials: In retrospective analysis, 72 patients of meibomian gland dysfunction were selected and divided into combination groups according to different treatment methods (n=32, iLux + 0.05% cyclosporine ophthalmic fluid) and the conventional group (n=44, 0.05% cyclosporine ophthalmic fluid). Compare the two groups of baseline data and clinical efficacy difference, compare the two groups after treatment eye symptoms, eye surface disease index score change.Results: Overall response rate of the combined group was higher than the conventional group (P < 0.05). Post-treatment, both groups were improved differently (P < 0.05), however, in the combined group, ocular symptom score, ocular surface disease index, conjunctival congestion score, corneal fluorescent staining score, meibomian gland (ostium condition score, lipid secretion shape score, deletion score) and interleukin-6, interleukin-1 β were all lower than those in the conventional group, The non-invasive mean tear film break-up time (NIBUTav), non-invasive first tear film break-up time (NIBUTf) and tear meniscus height in the combined group were higher than the conventional group (P < 0.05).Conclusion: ILux meibomian gland photothermal pulsation complex therapy instrument combined with 0.05% cyclosporine ophthalmic solution for the treatment of meibomian gland dysfunction.Keywords: meibomian gland dysfunction, iLux eyelid gland photothermal pulsatile compound therapy instrument, cyclosporine ophthalmic solution, treatment effect, patientshttps://www.dovepress.com/combination-of-ilux-photothermal-pulsation-therapy-with-005-cyclospori-peer-reviewed-fulltext-article-IJGMMeibomian gland dysfunctionILux eyelid gland photothermal pulsatile compound therapy instrumentCyclosporine ophthalmic solutionTreatment effectpatients
spellingShingle Xu H
Kang Q
Combination of iLux Photothermal Pulsation Therapy with 0.05% Cyclosporine in the Treatment of Meibomian Gland Dysfunction: A Clinical Study
International Journal of General Medicine
Meibomian gland dysfunction
ILux eyelid gland photothermal pulsatile compound therapy instrument
Cyclosporine ophthalmic solution
Treatment effect
patients
title Combination of iLux Photothermal Pulsation Therapy with 0.05% Cyclosporine in the Treatment of Meibomian Gland Dysfunction: A Clinical Study
title_full Combination of iLux Photothermal Pulsation Therapy with 0.05% Cyclosporine in the Treatment of Meibomian Gland Dysfunction: A Clinical Study
title_fullStr Combination of iLux Photothermal Pulsation Therapy with 0.05% Cyclosporine in the Treatment of Meibomian Gland Dysfunction: A Clinical Study
title_full_unstemmed Combination of iLux Photothermal Pulsation Therapy with 0.05% Cyclosporine in the Treatment of Meibomian Gland Dysfunction: A Clinical Study
title_short Combination of iLux Photothermal Pulsation Therapy with 0.05% Cyclosporine in the Treatment of Meibomian Gland Dysfunction: A Clinical Study
title_sort combination of ilux photothermal pulsation therapy with 0 05 cyclosporine in the treatment of meibomian gland dysfunction a clinical study
topic Meibomian gland dysfunction
ILux eyelid gland photothermal pulsatile compound therapy instrument
Cyclosporine ophthalmic solution
Treatment effect
patients
url https://www.dovepress.com/combination-of-ilux-photothermal-pulsation-therapy-with-005-cyclospori-peer-reviewed-fulltext-article-IJGM
work_keys_str_mv AT xuh combinationofiluxphotothermalpulsationtherapywith005cyclosporineinthetreatmentofmeibomianglanddysfunctionaclinicalstudy
AT kangq combinationofiluxphotothermalpulsationtherapywith005cyclosporineinthetreatmentofmeibomianglanddysfunctionaclinicalstudy